Key Findings:  The assay reliably confirmed the use of particular medical cannabis formulations in patient samples as well as reliably measured low CBD concentrations from single-dose CBD exposure.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Research Location(s):  United States
Year of Pub:  2019
Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabichromenic Acid (CBC-a), Cannabigerolic Acid (CBG-a), Tetrahydrocannabinolic Acid (THC-a), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source:  Not Applicable
Citation:  Roslawski MJ, et al. Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients. Ther Drug Monit. 2019; 41:357-370. doi: 10.1097/FTD.0000000000000583
Authors:  Roslawski MJ, Remmel RP, Karanam A, Leppik IE, Marino SE, Birnbaum AK